Allergy & Asthma Network Mothers of Asthmatics (AANMA)


Epi In the ER

Published March - 20 - 2014

epiERFirst come the hives … just a little rash on the cheek. Then a tingly sensation in the mouth … and a cough. Were there nuts in that cookie? Is this an allergic reaction? Anaphylaxis?

You don’t want to take a chance, so you call 911 or go directly to the local hospital emergency room (ER).

What then? Read the rest of this entry »

Proposed Asthma Inhalers Puts Patients at Risk

Published February - 20 - 2014

PrimateneVIENNA, VA, FEB. 19, 2014 – An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization.

On Feb. 25, FDA’s Nonprescription Drugs Advisory Committee and Read the rest of this entry »

Asthma Inhalers You Can ‘Count’ On

Published February - 18 - 2014



In April 2013, the Food and Drug Administration (FDA) issued draft guidance that could allow new generic quick-relief albuterol inhalers onto pharmacy shelves without dose counters, leaving asthma patients playing a dangerous guessing game.
Read the rest of this entry »

McLEAN, VA, NOV. 13, 2013 – Allergy & Asthma Network Mothers of Asthmatics (AANMA) today commended President Obama for signing into law the School Access to Emergency Epinephrine Act, legislation that helps protect schoolchildren who experience anaphylaxis, a life-threatening allergic reaction.

Read the rest of this entry »

FDA and Nasal Sprays

Published July - 18 - 2013

Do you – or someone in your family – use a corticosteroid nasal spray?

On July 31, AANMA released results of our recent survey regarding patient use of intranasal corticosteroid sprays. Findings were shared during the Food and Drug Administration (FDA) Nonprescription Drug Advisory Committee meeting considering the switch of triamcinolone nasal spray from prescription to over-the-counter status.

Read the rest of this entry »

Primatene Mist: Going, Going, Gone

Published December - 16 - 2011

After more than 50 years on the market, Primatene® Mist, the only nonprescription bronchodilator inhaler, will no longer be manufactured, sold or distributed in the United States as of Dec. 31, 2011. Why not? Because Primatene Mist, which is inhaled epinephrine, contains chlorofluorcarbon (CFC) propellants.

Read the rest of this entry »

Kelsey never leaves home without it – her auto-injectable epinephrine, that is. In fact she always has two. You see, Kelsey is allergic to peanuts and while she does everything she can to avoid being exposed to them, she knows that accidents happen, Read the rest of this entry »

“With today’s news, we are able to reassure patients of the safety of these medications when used according to newly clarified label instructions Read the rest of this entry »

Nasal Allergies? Sniff This!

Published June - 1 - 2010

A look at how and why to use nasal sprays

Nasal asthma. Ever heard of it? Probably not, because I just made it up. Before you thumb your nose at the idea, consider that the nose and lower airways are all part of the respiratory pathway and share similar immune responses to allergens, irritants and viruses. And while it is possible to have one condition without the other, for many of us, nasal symptoms (rhinitis) usually herald the onset of asthma symptoms to come.

Read the rest of this entry »

nebulizerchallengeBy Laurie Ross
Ivory-tower research studies say that metered-dose inhalers (when used correctly either with or without a valved holding chamber) are just as effective as nebulizers at getting medication deep into your airways. However, many of you have told us otherwise: Inhalers are great when you’re out and about, but if you’re under the weather and feeling short of breath, there’s nothing more therapeutic than inhaling the cool, medicated mist of your trusty nebulizer. Read the rest of this entry »